Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.135 AUD | +8.00% | +3.85% | -3.57% |
May. 02 | Little Green Pharma Welcomes Proposed Classification Downgrade of Cannabis in the US; Shares Rise 4% | MT |
Apr. 17 | EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections | AN |
Valuation
Fiscal Period: March | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 131.1 | 116.5 | 40.71 | - | - |
Enterprise Value (EV) 1 | 131.1 | 116.5 | 39.01 | 41.71 | 41.41 |
P/E ratio | 4.72 x | -6.34 x | -67.5 x | -13.5 x | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | - | 1.59 x | 1.37 x | 1.15 x |
EV / Revenue | - | - | 1.52 x | 1.4 x | 1.17 x |
EV / EBITDA | - | - | 11.5 x | 209 x | 12.9 x |
EV / FCF | - | - | -17 x | -16.7 x | 82.8 x |
FCF Yield | - | - | -5.9% | -5.99% | 1.21% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 187,275 | 240,211 | 301,551 | - | - |
Reference price 2 | 0.7000 | 0.4850 | 0.1350 | 0.1350 | 0.1350 |
Announcement Date | 8/30/21 | 6/30/22 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | - | 25.6 | 29.8 | 35.5 |
EBITDA 1 | - | - | 3.4 | 0.2 | 3.2 |
EBIT 1 | - | - | 0.4 | -2.7 | 0.4 |
Operating Margin | - | - | 1.56% | -9.06% | 1.13% |
Earnings before Tax (EBT) 1 | - | - | -0.5 | -3 | 0.1 |
Net income 1 | 24.6 | -18.29 | -0.5 | -3 | 0.1 |
Net margin | - | - | -1.95% | -10.07% | 0.28% |
EPS 2 | 0.1484 | -0.0765 | -0.002000 | -0.0100 | - |
Free Cash Flow 1 | - | - | -2.3 | -2.5 | 0.5 |
FCF margin | - | - | -8.98% | -8.39% | 1.41% |
FCF Conversion (EBITDA) | - | - | - | - | 15.62% |
FCF Conversion (Net income) | - | - | - | - | 500% |
Dividend per Share | - | - | - | - | - |
Announcement Date | 8/30/21 | 6/30/22 | - | - | - |
Balance Sheet Analysis
Fiscal Period: March | 2021 | 2022 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | 1 | 0.7 |
Net Cash position 1 | - | - | 1.7 | - | - |
Leverage (Debt/EBITDA) | - | - | - | 5 x | 0.2187 x |
Free Cash Flow 1 | - | - | -2.3 | -2.5 | 0.5 |
ROE (net income / shareholders' equity) | - | - | -0.3% | -2.1% | 0.1% |
ROA (Net income/ Total Assets) | - | - | -0.3% | -2% | 0.1% |
Assets 1 | - | - | 166.7 | 150 | 100 |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share 2 | - | - | 0 | -0.0100 | 0.0100 |
Capex 1 | - | - | 1.4 | 1.1 | 1.1 |
Capex / Sales | - | - | 5.47% | 3.69% | 3.1% |
Announcement Date | 8/30/21 | 6/30/22 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.57% | 24.95M | |
+43.96% | 6.32B | |
-15.56% | 4.49B | |
-6.52% | 3.3B | |
+5.47% | 3.19B | |
-0.76% | 2.6B | |
+56.34% | 2.05B | |
-4.11% | 1.77B | |
+2.93% | 1.7B | |
-8.02% | 1.63B |
- Stock Market
- Equities
- LGP Stock
- Financials Little Green Pharma Ltd